SUMO modification regulates the transcriptional activity of FLASH

Biochemical and Biophysical Research Communications

Volumn 387, Issue 3, 2009, Pages 494-499

  Alm Kristiansen, Anne Hege ^a   Norman, Ingrid Louise ^a   Matre, Vilborg ^a   Gabrielsen, Odd Stokke ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

CASP8AP2; FLASH; SENP1; SUMO 1; Transcription; Ubc9

Indexed keywords

PROTEIN; PROTEIN FLASH; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MODIFICATION; SUMOYLATION; TWO HYBRID SYSTEM;

APOPTOSIS REGULATORY PROTEINS; CALCIUM-BINDING PROTEINS; CELL NUCLEUS; HUMANS; LYSINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-CONJUGATING ENZYMES;

EID: 68249099992     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.053     Document Type: Article

References (23)

1. Imai Y., Kimura T., Murakami A., Yajima N., Sakamaki K., and Yonehara S. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398 (1999) 777-785
2. Alm-Kristiansen A.H., Saether T., Matre V., Gilfillan S., Dahle O., and Gabrielsen O.S. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci. Oncogene 27 (2008) 4644-4656
3. Kino T., and Chrousos G.P. Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators. J. Biol. Chem. 278 (2003) 3023-3029
4. Kino T., Ichijo T., and Chrousos G.P. FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors. J. Steroid Biochem. Mol. Biol. 92 (2004) 357-363
5. Obradovic D., Tirard M., Nemethy Z., Hirsch O., Gronemeyer H., and Almeida O.F. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors?. Mol. Pharmacol. 65 (2004) 761-769
6. Barcaroli D., Bongiorno-Borbone L., Terrinoni A., Hofmann T.G., Rossi M., Knight R.A., Matera A.G., Melino G., and De Laurenzi V. FLASH is required for histone transcription and S-phase progression. Proc. Natl. Acad. Sci. USA 103 (2006) 14808-14812
7. Barcaroli D., Dinsdale D., Neale M.H., Bongiorno-Borbone L., Ranalli M., Munarriz E., Sayan A.E., McWilliam J.M., Smith T.M., Fava E., Knight R.A., Melino G., and De Laurenzi V. FLASH is an essential component of Cajal bodies. Proc. Natl. Acad. Sci. USA 103 (2006) 14802-14807
8. Milovic-Holm K., Krieghoff E., Jensen K., Will H., and Hofmann T.G. FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J. 26 (2007) 391-401
9. Krieghoff E., Milovic-Holm K., and Hofmann T.G. FLASH meets nuclear bodies: CD95 receptor signals via a nuclear pathway. Cell Cycle 6 (2007) 771-775
10. Hay R.T. SUMO: a history of modification. Mol. Cell 18 (2005) 1-12
11. Geiss-Friedlander R., and Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8 (2007) 947-956
12. Mukhopadhyay D., and Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32 (2007) 286-295
13. Yang S.H., Galanis A., Witty J., and Sharrocks A.D. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25 (2006) 5083-5093
14. Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J., Nakai A., and Sistonen L. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. USA 103 (2006) 45-50
15. Wei F., Scholer H.R., and Atchison M.L. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 282 (2007) 21551-21560
16. Terui Y., Saad N., Jia S., McKeon F., and Yuan J. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279 (2004) 28257-28265
17. Sampson D.A., Wang M., and Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276 (2001) 21664-21669
18. Pichler A., Gast A., Seeler J.S., Dejean A., and Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108 (2002) 109-120
19. Kotaja N., Karvonen U., Janne O.A., and Palvimo J.J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22 (2002) 5222-5234
20. Sewalt R.G., Gunster M.J., van der Vlag J., Satijn D.P., and Otte A.P. C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate polycomb proteins. Mol. Cell. Biol. 19 (1999) 777-787
21. Gong L., Millas S., Maul G.G., and Yeh E.T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275 (2000) 3355-3359
22. Kotaja N., Karvonen U., Janne O.A., and Palvimo J.J. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J. Biol. Chem. 277 (2002) 30283-30288
23. Meinecke I., Cinski A., Baier A., Peters M.A., Dankbar B., Wille A., Drynda A., Mendoza H., Gay R.E., Hay R.T., Ink B., Gay S., and Pap T. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc. Natl. Acad. Sci. USA 104 (2007) 5073-5078